Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

1 week ago 8
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

Related

China pivots to Europe for used cooking oil exports as tariffs hit shipments to US

China pivots to Europe for used cooking oil exports as tarif...

2 hours ago 0
Coca-Cola HBC beats quarterly revenue growth estimates

Coca-Cola HBC beats quarterly revenue growth estimates

2 hours ago 0
Jubilee Metals advances copper trials in Zambia

Jubilee Metals advances copper trials in Zambia

2 hours ago 0
RIGHT SIDEBAR TOP AD

Trending

1. demi lovato
2. final destination bloodlines
3. cubs - pirates
4. lubbock weather
5. heather graham
6. matthew gray gubler
7. tony gonsolin
8. wayne brady
9. rashad mccants
10. mark henry

Popular

What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

2 weeks ago 87
Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

2 weeks ago 85
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

2 weeks ago 74
Biden reemerges on the attack, but doesn’t mention Trump

Biden reemerges on the attack, but doesn’t mention Trump

2 weeks ago 71
From classifying immigrants as dead to deportation: A guide to actions on Trump immigration policies

From classifying immigrants as dead to deportation: A guide ...

2 weeks ago 70
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved